You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 20, May 26, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation.
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonblack Patients With Sickle Cell Disease Have African βs Gene Cluster Haplotypes

Zora R. Rogers, MD; Darleen R. Powars, MD; Thomas R. Kinney, MD; W. Donald Williams, MD; Walter A. Schroeder, PhD

JAMA. 1989;261(20):2991-2994.


Abstract

Of 18 nonblack patients with sickle cell disease, 14 had sickle cell anemia, 2 had hemoglobin SC disease, and 2 had hemoglobin S-β°-thalassemia. The βs gene cluster haplotypes that were determined in 7 patients were of African origin and were identified as Central African Republic, Central African Republic minor II, Benin, and Senegal. The haplotype Central African Republic minor II was present on the β°-thalassemia. chromosome in 2 patients. None of 10 patients whose {alpha}-gene status was determined had {alpha}-thalassemia-2. These data strongly support the concept that the βs gene on chromosome 11 of these individuals is of African origin and that the {alpha}-gene locus on chromosome 16 is of white or native American origin. The clinical severity of the disease in these nonblack patients is appropriate to their haplotype without {alpha}-thalassemia-2 and is comparable with that of black patients. All persons with congenital hemolytic anemia should be examined for the presence of sickle cell disease regardless of physical appearance or ethnic background.

(JAMA. 1989;261:2991-2994)



Author Affiliations

From the Department of Pediatrics, the Division of Hematology, University of Southern California School of Medicine, Los Angeles (Drs Rogers, Powars, and Williams); the Department of Pediatrics, the Division of Hematology, Duke University, Durham, NC (Dr Kinney); and the Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena (Dr Schroeder).


Footnotes

Reprint requests to Los Angeles County/University of Southern California Medical Center, 1129 N State St, Room 2E19, Los Angeles, CA 90033 (Dr Powars).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

First Unaffected Pregnancy Using Preimplantation Genetic Diagnosis for Sickle Cell Anemia
Xu et al.
JAMA 1999;281:1701-1706.
ABSTRACT | FULL TEXT  

Sickle Cell Disease in Nonblack Persons
JAMA 1994;271:1885-1885.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.